CD4+ levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD4+ levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodies
Authors
Keywords
Immune response, Macaque, Antibodies, Antibody response, Binding analysis, Enzyme-linked immunoassays, Blood plasma, Antigens
Journal
PLoS One
Volume 12, Issue 11, Pages e0187912
Publisher
Public Library of Science (PLoS)
Online
2017-11-10
DOI
10.1371/journal.pone.0187912
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses
- (2017) David Druzd et al. IMMUNITY
- Regulation of germinal center responses, memory B cells and plasma cell formation—an update
- (2016) Lynn M Corcoran et al. CURRENT OPINION IN IMMUNOLOGY
- Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial
- (2016) Joanna E. Long et al. VACCINE
- Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study
- (2015) R. E. Donahue et al. BLOOD
- Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
- (2015) R. Tavare et al. JOURNAL OF NUCLEAR MEDICINE
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- Antibody-based imaging strategies for cancer
- (2014) Jason M. Warram et al. CANCER AND METASTASIS REVIEWS
- Antibody-Based Imaging of HER-2: Moving into the Clinic
- (2013) R. Wang et al. CURRENT MOLECULAR MEDICINE
- Monoclonal antibody therapeutics: history and future
- (2012) Nicholas APS Buss et al. CURRENT OPINION IN PHARMACOLOGY
- Long-Lived Bone Marrow Plasma Cells Are Induced Early in Response to T Cell-Independent or T Cell-Dependent Antigens
- (2012) A. Bortnick et al. JOURNAL OF IMMUNOLOGY
- Advances in the assessment and control of the effector functions of therapeutic antibodies
- (2011) Xu-Rong Jiang et al. NATURE REVIEWS DRUG DISCOVERY
- Immunogenicity of Therapeutic Proteins: The Use of Animal Models
- (2011) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy
- (2010) Alberto Cagigi et al. LANCET INFECTIOUS DISEASES
- Have we overestimated the benefit of human(ized) antibodies?
- (2010) Daniel R. Getts et al. mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates
- (2009) M. Di Mascio et al. BLOOD
- Randomized, Double‐Blind Comparative Trial of Subunit and Virosomal Influenza Vaccines for Immunocompromised Patients
- (2009) John Evison et al. CLINICAL INFECTIOUS DISEASES
- Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy
- (2009) Alessandra Viganò et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Origin and evolution of the adaptive immune system: genetic events and selective pressures
- (2009) Martin F. Flajnik et al. NATURE REVIEWS GENETICS
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical immunotoxicity of therapeutic proteins
- (2008) Jacques Descotes et al. Expert Opinion on Drug Metabolism & Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More